Harvard Bioscience, Inc.

NASDAQ

Market Cap.

16.54M

Avg. Volume

343.79K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Harvard Bioscience, Inc.

Harvard Bioscience, Inc. News

Harvard Bioscience, Inc. Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock
Website screenshot
HealthcareMedical - Instruments & Supplies
harvardbioscience.com

About Harvard Bioscience, Inc.

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ-based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments. It also engages in the development and manufacture of precision scientific measuring instrumentation and equipment, which cover data acquisition systems with custom amplifier configurations for cellular analysis, micro electrode array solutions for in vivo recordings, and vitro-systems for extracellular recordings; and offers preclinical products. The company markets its products through sales organizations, websites, catalogs, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories, as well as to contract research organizations, academic labs, and government researchers. It primarily sells its products under Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS brand names. The company was founded in 1901 and is headquartered in Holliston, Massachusetts.

Harvard Bioscience, Inc. Earnings & Revenue

Harvard Bioscience, Inc. Financials

Table Compare

Compare HBIO metrics with:

   

Earnings & Growth

HBIO

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

HBIO

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

HBIO

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

HBIO

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Harvard Bioscience, Inc. Income

Harvard Bioscience, Inc. Balance Sheet

Harvard Bioscience, Inc. Cash Flow

Harvard Bioscience, Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityStrong Sell
Return on AssetsStrong Sell
Debt/Equity RatioStrong Sell
Price/Earnings RatioStrong Sell
Price/Book RatioNeutral

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Harvard Bioscience, Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Historical Market Cap

Shares Outstanding

Harvard Bioscience, Inc. Executives

NameRole
Mr. James W. GreenPresident, Chief Executive Officer & Chairman
Kathryn FlynnCorporate Controller
David SiroisDirector of Corporate Accounting & SEC Reporting
Mr. John J. Fry J.D.Chief Legal Counsel & Corporation Secretary
Mr. Ryan WallaceSenior Vice President of Global Sales
NameRoleGenderDate of BirthPay
Mr. James W. GreenPresident, Chief Executive Officer & ChairmanMale1958536.58K
Kathryn FlynnCorporate Controller

--

David SiroisDirector of Corporate Accounting & SEC Reporting

--

Mr. John J. Fry J.D.Chief Legal Counsel & Corporation SecretaryMale1961

--

Mr. Ryan WallaceSenior Vice President of Global SalesMale

--

Harvard Bioscience, Inc. Insider Trades

Date19 Mar
NameCote Jennifer
RoleChief Financial Officer
TransactionDisposed
TypeF-InKind
Shares5687
Date19 Mar
NameGreen James W
RoleChief Executive Officer
TransactionDisposed
TypeF-InKind
Shares38413
Date31 Dec
NameGreen James W
RoleChief Executive Officer
TransactionDisposed
TypeD-Return
Shares145365
Date29 Dec
NameGreen James W
RoleChief Executive Officer
TransactionDisposed
TypeF-InKind
Shares56915
Date29 Dec
NameGreen James W
RoleChief Executive Officer
TransactionDisposed
TypeF-InKind
Shares25310
DateNameRoleTransactionTypeShares
19 MarCote JenniferChief Financial OfficerDisposedF-InKind5687
19 MarGreen James WChief Executive OfficerDisposedF-InKind38413
31 DecGreen James WChief Executive OfficerDisposedD-Return145365
29 DecGreen James WChief Executive OfficerDisposedF-InKind56915
29 DecGreen James WChief Executive OfficerDisposedF-InKind25310

Discover More

Streamlined Academy

Harvard Bioscience, Inc.

NASDAQ

Market Cap.

16.54M

Avg. Volume

343.79K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Harvard Bioscience, Inc. News

Harvard Bioscience, Inc. Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock

Harvard Bioscience, Inc. Earnings & Revenue

Harvard Bioscience, Inc. Income

Harvard Bioscience, Inc. Balance Sheet

Harvard Bioscience, Inc. Cash Flow

Harvard Bioscience, Inc. Financials Over Time

Harvard Bioscience, Inc. Executives

NameRole
Mr. James W. GreenPresident, Chief Executive Officer & Chairman
Kathryn FlynnCorporate Controller
David SiroisDirector of Corporate Accounting & SEC Reporting
Mr. John J. Fry J.D.Chief Legal Counsel & Corporation Secretary
Mr. Ryan WallaceSenior Vice President of Global Sales
NameRoleGenderDate of BirthPay
Mr. James W. GreenPresident, Chief Executive Officer & ChairmanMale1958536.58K
Kathryn FlynnCorporate Controller

--

David SiroisDirector of Corporate Accounting & SEC Reporting

--

Mr. John J. Fry J.D.Chief Legal Counsel & Corporation SecretaryMale1961

--

Mr. Ryan WallaceSenior Vice President of Global SalesMale

--

Harvard Bioscience, Inc. Insider Trades

Date19 Mar
NameCote Jennifer
RoleChief Financial Officer
TransactionDisposed
TypeF-InKind
Shares5687
Date19 Mar
NameGreen James W
RoleChief Executive Officer
TransactionDisposed
TypeF-InKind
Shares38413
Date31 Dec
NameGreen James W
RoleChief Executive Officer
TransactionDisposed
TypeD-Return
Shares145365
Date29 Dec
NameGreen James W
RoleChief Executive Officer
TransactionDisposed
TypeF-InKind
Shares56915
Date29 Dec
NameGreen James W
RoleChief Executive Officer
TransactionDisposed
TypeF-InKind
Shares25310
DateNameRoleTransactionTypeShares
19 MarCote JenniferChief Financial OfficerDisposedF-InKind5687
19 MarGreen James WChief Executive OfficerDisposedF-InKind38413
31 DecGreen James WChief Executive OfficerDisposedD-Return145365
29 DecGreen James WChief Executive OfficerDisposedF-InKind56915
29 DecGreen James WChief Executive OfficerDisposedF-InKind25310

Streamlined Academy

Website screenshot
HealthcareMedical - Instruments & Supplies
harvardbioscience.com

About Harvard Bioscience, Inc.

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ-based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments. It also engages in the development and manufacture of precision scientific measuring instrumentation and equipment, which cover data acquisition systems with custom amplifier configurations for cellular analysis, micro electrode array solutions for in vivo recordings, and vitro-systems for extracellular recordings; and offers preclinical products. The company markets its products through sales organizations, websites, catalogs, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories, as well as to contract research organizations, academic labs, and government researchers. It primarily sells its products under Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS brand names. The company was founded in 1901 and is headquartered in Holliston, Massachusetts.

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Harvard Bioscience, Inc.

Harvard Bioscience, Inc. Financials

Table Compare

Compare HBIO metrics with:

   

Earnings & Growth

HBIO

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

HBIO

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

HBIO

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

HBIO

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Harvard Bioscience, Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityStrong Sell
Return on AssetsStrong Sell
Debt/Equity RatioStrong Sell
Price/Earnings RatioStrong Sell
Price/Book RatioNeutral

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More

A Practical Guide: How To Analyze Any Stock (With Examples)